These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

442 related items for PubMed ID: 15772704

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Should patients with chronic heart failure be treated with "statins"?
    Ashton E, Liew D, Krum H.
    Heart Fail Monit; 2003; 3(3):82-6. PubMed ID: 12634877
    [Abstract] [Full Text] [Related]

  • 5. Models for describing relations among the various statin drugs, low-density lipoprotein cholesterol lowering, pleiotropic effects, and cardiovascular risk.
    Robinson JG.
    Am J Cardiol; 2008 Apr 01; 101(7):1009-15. PubMed ID: 18359323
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The effects of statins on endothelium, inflammation and cardioprotection.
    Elrod JW, Lefer DJ.
    Drug News Perspect; 2005 May 01; 18(4):229-36. PubMed ID: 16034478
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [The role of HMG-CoA reductase inhibitors in regulation of the inflammatory processes].
    Cecha J, Drabek G, Błazelonis A, Romanowski W, Zubelewicz-Szkodzińska B.
    Wiad Lek; 2004 May 01; 57(5-6):255-8. PubMed ID: 15518071
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Statin-associated pleiotropy: possible beneficial effects beyond cholesterol reduction.
    Ito MK, Talbert RL, Tsimikas S.
    Pharmacotherapy; 2006 Jul 01; 26(7 Pt 2):85S-97S; discussion 98S-101S; quiz 106S-108S. PubMed ID: 16803418
    [Abstract] [Full Text] [Related]

  • 15. Neutral effect on markers of heart failure, inflammation, endothelial activation and function, and vagal tone after high-dose HMG-CoA reductase inhibition in non-diabetic patients with non-ischemic cardiomyopathy and average low-density lipoprotein level.
    Bleske BE, Nicklas JM, Bard RL, Brook RD, Gurbel PA, Bliden KP, Rajagopalan S, Pitt B.
    J Am Coll Cardiol; 2006 Jan 17; 47(2):338-41. PubMed ID: 16412857
    [Abstract] [Full Text] [Related]

  • 16. Beneficial cardiovascular pleiotropic effects of statins.
    Davignon J.
    Circulation; 2004 Jun 15; 109(23 Suppl 1):III39-43. PubMed ID: 15198965
    [Abstract] [Full Text] [Related]

  • 17. Microcirculation as a target for the anti-inflammatory properties of statins.
    Scalia R, Stalker TJ.
    Microcirculation; 2002 Dec 15; 9(6):431-42. PubMed ID: 12483541
    [Abstract] [Full Text] [Related]

  • 18. Intermolecular differences of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors contribute to distinct pharmacologic and pleiotropic actions.
    Mason RP, Walter MF, Day CA, Jacob RF.
    Am J Cardiol; 2005 Sep 05; 96(5A):11F-23F. PubMed ID: 16126019
    [Abstract] [Full Text] [Related]

  • 19. Potential vascular benefits of statins.
    Kinlay S.
    Am J Med; 2005 Dec 05; 118 Suppl 12A():62-7. PubMed ID: 16356810
    [Abstract] [Full Text] [Related]

  • 20. [Statins in chronic heart failure--new indication?].
    Broncel M, Koziróg M, Chojnowska-Jezierska J.
    Pol Merkur Lekarski; 2006 Jun 05; 20(120):710-2. PubMed ID: 17007276
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.